M4MM
Tilray Acquires HelloMD to Build Out Canadian Medical Cannabis Network
NEW YORK – Tilray Brands Inc. has agreed to acquire HelloMD Corporation’s Canadian medical Cannabis assets, in a deal the companies say will build a fully vertically integrated medical Cannabis structure in Canada and add ...
DEA Opens Hearing on Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
DEA Opens Hearing on Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Georgia Expands Access to Medical Cannabis
ATLANTA – A revised medical Cannabis law takes effect in Georgia on Wednesday, broadening the conditions that qualify patients for legal access and permitting vaporization as an approved method of use for the first time. ...
Tilray Acquires HelloMD to Build Out Canadian Medical Cannabis Network
NEW YORK – Tilray Brands Inc. has agreed to acquire HelloMD Corporation’s Canadian medical Cannabis assets, in a deal the companies say will build a fully vertically integrated medical Cannabis structure in Canada and add ...
DEA Opens Hearing on Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Ora Pharm Completes Helius Acquisition, Becomes New Zealand’s Largest Medical Cannabis Company
AUCKLAND – Ora Pharm has completed the acquisition of the key assets of Helius Therapeutics and restarted manufacturing operations. The agreement covers Helius's EU-GMP-certified production plant, its remaining inventory, and its operating licenses, though it ...
Glass House Brands Triggers Warrant Acceleration
LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Two weeks of headlines confirm a market sorting itself by balance sheet rather than by ambition. Cannabis is consolidating into a smaller circle of disciplined operators, while psychedelics graduate from pilot programs ...
Virginia Lawmakers Send Cannabis Retail Framework to Governor’s Desk
RICHMOND – The Virginia General Assembly approved budget language that sets the terms for a regulated adult-use Сannabis market, sending the measure to Gov. Abigail Spanberger after a year of stalled bills and one rejected ...
Definium Clears Phase 3 Trial for its LSD-Based Depression Treatment
NEW YORK – Definium Therapeutics Inc. announced positive topline data from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet (ODT) formulation of pharmaceutical LSD, in adults with major depressive disorder (MDD). The ...
Vireo Growth Finalizes Equity Stake in Two Maryland Dispensaries
MINNEAPOLIS – Vireo Growth Inc. announced that it has completed the acquisition of an indirect 49% equity interest in HA-MD, LLC, the entity that owns Chesapeake Integrated Health Institute and Maryland Alternative Relief, two licensed ...
Khalifa Kush Enters Australia Through Endoca Distribution Deal
LOS ANGELES – Khalifa Kush, the Cannabis brand founded by rapper Wiz Khalifa, has struck a distribution agreement with Australian medicinal Cannabis company Endoca to bring its flower, edibles and vape cartridges to patients across ...
Otsuka Completes $1.23B Buyout of Transcend Therapeutics
PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical Co., Ltd., announced that it has completed its acquisition of Transcend Therapeutics, a New York biotechnology company developing rapid-acting treatments for neuropsychiatric disease. First disclosed ...
North Carolina Lawmakers Unite Behind Psychedelic Research Bill for Veterans
RALEIGH – NC Lawmakers from both parties held a press conference at the General Assembly to support legislation that would direct state funding toward research on psilocybin, MDMA, and ibogaine as treatments for PTSD and ...
Glass House Brands Applies for NYSE Uplisting
LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...
Virginia Governor and Lawmakers Announce Agreement on Legal Cannabis Sales
RICHMOND – Governor Abigail Spanberger, State Senator Lashrecse Aird (D), and Delegate Paul Krizek (D), announced they had reached a compromise to establish a legal, regulated retail cannabis market. This marks the culmination of a ...
Splash Beverage Group Completes Strategic Investment in Avicanna, Transforms into Cannabinoid Healthcare
FORT LAUDERDALE – Splash Beverage Group Inc. announced the completion of a CDN$300,000 (~USD$217,479) minority investment in Avicanna Inc., a commercial-stage international biopharmaceutical company headquartered in Toronto, Canada. The transaction involved Splash acquiring 2,000,000 common ...
Canopy Growth Reports Q4 and FY 2026 Financial Results
SMITHS FALLS – Canopy Growth Corp. reported consolidated net revenue of $71.2 million for the quarter, up 10% from the prior year. For the full fiscal year, net revenue reached $284.6 million, a 6% increase ...
High Tide Secures C$40M Credit Approval, Expands Ontario Footprint with Northern Helm Acquisition
CALGARY – High Tide Inc. continues to build its position as a major player in Canadian Сannabis retail. The company, which operates the Canna Cabana chain, signed a definitive agreement to acquire four Ontario retail ...
Vireo Growth to Acquire Nevada-Based C21 Investments
MINNEAPOLIS – In a move that underscores ongoing efforts by larger players to strengthen their positions in key state markets, Vireo Growth Inc. and C21 Investments Inc. have entered into a definitive arrangement agreement. The ...
